A Look at Associated Banc-Corp’s Valuation Following Record Net Interest Income and Commercial Loan Growth

Associated Banc-Corp (ASB) caught investors’ attention after its second quarter earnings presentation highlighted record net interest income and a 13% rise in commercial and industrial loans over the past year. The company’s updated guidance also points to ongoing strategic momentum.

See our latest analysis for Associated Banc-Corp.

Despite a bumpy few weeks, Associated Banc-Corp's 1-year total shareholder return stands at nearly 8%, and the five-year figure is an impressive 106%, hinting at real staying power. Recent share price weakness likely reflects shifting investor sentiment after a strong run and anticipation of how the company will deploy its commercial loan growth and credit risk innovations going forward.

If you're weighing opportunities beyond the banking sector, now is a smart moment to broaden your search and discover fast growing stocks with high insider ownership

With shares trading at a meaningful discount to analyst targets and robust credit and loan growth on display, does this mark a compelling entry point for investors, or has the market already accounted for Associated Banc-Corp’s future gains?

Most Popular Narrative: 15.7% Undervalued

Based on the most widely followed narrative, Associated Banc-Corp’s fair value is estimated at $28.60 per share, compared to a last close of $24.11. This places the stock noticeably below the narrative fair value and sets the context for a valuation case built on growth and margin expansion.

The company's strategic pivot toward growing commercial and industrial (C&I) lending, replacing lower-yielding residential balances with higher-yielding, relationship-focused assets, is driving record net interest income and margin expansion. This is positioning the balance sheet for sustained profitability growth and is likely to positively impact revenue and net margins.

Read the complete narrative.

What is supporting this price target? The narrative leans heavily on ambitious earnings projections and a substantial jump in profit margins. Curious which numbers analysts are really betting on? Uncover the growth forecasts and profitability assumptions fueling this compelling valuation argument.

Result: Fair Value of $28.60 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, any slowdown in deposit growth or an increase in credit losses in commercial lending could quickly challenge these optimistic projections for Associated Banc-Corp.

Find out about the key risks to this Associated Banc-Corp narrative.

Another View: What Do Valuation Ratios Suggest?

While analyst forecasts point to Associated Banc-Corp being undervalued, valuation ratios tell a different story. The company trades at 31 times earnings, which is more expensive than both the US Banks industry average of 11.6x and the peer average of 29.2x. This large gap may signal premium expectations and introduce valuation risk if growth does not meet forecasts. Will the market continue to reward the stock, or is a re-rating due?

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own Associated Banc-Corp Narrative

If you see things differently, or want to dive into the numbers yourself, you can craft your own narrative in just a few minutes. Do it your way

A great starting point for your Associated Banc-Corp research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.

Looking for more investment ideas?

Great investors seize timely opportunities. Give yourself an edge by checking out these hand-picked stock themes using the Simply Wall Street Screener before the next market move.

• Capture dividend income potential by scanning these 20 dividend stocks with yields > 3%. These stocks offer yields above 3% and can power steady returns in any environment.
• Tap into the future of medicine by viewing these 33 healthcare AI stocks. These companies are bringing AI innovation to the healthcare space.
• Unleash growth opportunities among digital trailblazers by browsing these 79 cryptocurrency and blockchain stocks, which features companies transforming the blockchain and crypto landscape.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com